# Sophia Genetics (SOPH): value investors who own it

1 value investor held Sophia Genetics in their Q3 2026 13F, led by Akre Capital Management. See who bought, sold and how ownership has changed by quarter.

## 13F holders

| Manager | Portfolio | Value | Change | Quarters held |
| --- | --- | --- | --- | --- |
| Akre Capital Management | 0.4% | $21.5m | Unchanged | 10 |

## Directors buying and selling (Form 4, last 12 months)

| Date | Who | Role | Bought or sold | Shares | Value |
| --- | --- | --- | --- | --- | --- |
| 2026-10-13 | Xu Zhenyu | Chief Scientific Officer | Sold | 4000 | $29k |
| 2026-10-12 | Camblong Jurgi | Executive Chairman | Sold | 8500 | $62k |
| 2026-10-12 | Menu Philippe | Chief Medical Officer | Sold | 5000 | $36k |
| 2026-10-05 | Camblong Jurgi | Executive Chairman | Sold | 40172 | $327k |
| 2026-10-05 | Muken Ross | Chief Executive Officer | Sold | 9838 | $80k |
| 2026-10-05 | Menu Philippe | Chief Medical Officer | Sold | 7394 | $60k |
| 2026-10-05 | Xu Zhenyu | Chief Scientific Officer | Sold | 7394 | $60k |
| 2026-10-05 | Van Well Daan | Chief Legal Officer | Sold | 6168 | $50k |
| 2026-10-05 | Verma Abhimanyu | Chief Technology Officer | Sold | 5284 | $43k |
| 2026-10-05 | Valente Manuela | Chief People Officer | Sold | 4240 | $34k |
| 2026-10-05 | CARDOZA GEORGE | Chief Financial Officer | Sold | 1592 | $13k |
| 2026-10-05 | Puylaert Kevin | Chief Sales Officer | Sold | 185 | $1k |
| 2026-10-05 | Puylaert Kevin | Chief Sales Officer | Sold | 31 | $0k |
| 2026-09-21 | CARDOZA GEORGE | Chief Financial Officer | Sold | 774 | $6k |
| 2026-09-21 | Muken Ross | Chief Executive Officer | Sold | 422 | $4k |
| 2026-09-14 | Menu Philippe | Chief Medical Officer | Sold | 5000 | $39k |
| 2026-09-14 | Xu Zhenyu | Chief Scientific Officer | Sold | 4000 | $32k |
| 2026-09-11 | Van Well Daan | Chief Legal Officer | Sold | 6168 | $47k |
| 2026-09-10 | Camblong Jurgi | Executive Chairman | Sold | 8500 | $65k |
| 2026-09-08 | HIBBS KATHY L | Director | Sold | 6250 | $51k |

Source: SEC filings, via moatshark (https://www.moatshark.com/s/soph). Values traded and returns are estimates. Not investment advice. Built 2026-10-21.